Antifibrinolytic agents for ruptured intracranial aneurysms.
D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D002532:Intracranial Aneurysm / Q000188:drug therapy*; D012422:Rupture, Spontaneous; D014148:Tranexamic Acid / Q000627:therapeutic use*
D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid